Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 EUR | -0.76% | +1.15% | -56.15% |
May. 22 | Transcript : Marinomed Biotech AG, Q1 2024 Earnings Call, May 22, 2024 | |
May. 21 | Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Virology
99.3
%
| 11 | 99.3 % | 9 | 99.3 % | -18.60% |
Other
0.7
%
| 0 | 0.7 % | 0 | 0.7 % | -12.87% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other European Countries
50.9
%
| 7 | 60.8 % | 5 | 50.9 % | -31.82% |
Non-European Countries
43.3
%
| 3 | 30.4 % | 4 | 43.3 % | +15.73% |
Austria
5.8
%
| 1 | 8.8 % | 1 | 5.8 % | -45.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 05-12-31 | |
Founder | 56 | 05-12-31 | |
Pascal Schmidt
DFI | Director of Finance/CFO | 52 | 18-07-31 |
Chief Operating Officer | - | 10-12-31 | |
Renate Moser
PRN | Corporate Officer/Principal | - | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 07-12-31 | |
Brigitte Ederer
BRD | Director/Board Member | 68 | 18-11-20 |
Director/Board Member | - | 22-06-14 | |
Ulrich Kinzel
BRD | Director/Board Member | 60 | 22-06-14 |
Director/Board Member | - | 23-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,540,530 | 1,002,892 ( 65.10 %) | 0 | 65.10 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.76% | 32.56B | |
-11.69% | 15.98B | |
-0.30% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- MARI Stock
- 93Z Stock
- Company Marinomed Biotech AG